FMO5 and infection: Prophylactic administration of SMZ (cotrimoxazole) and itraconazole significantly reduces infection rates.[20] IFN-γ therapy enhances residual NADPH oxidase activity and boosts host immune defense.[21] For active infections, early and targeted use of broad-spectrum antibiotics and antifungal agents is critical.